122 related articles for article (PubMed ID: 9177471)
1. 1alpha,25-dihydroxyvitamin D3 activates T cells of tumor bearers through protein phosphatase 2A.
Wiers KM; Lozano Y; Messingham KA; Metz RJ; Young MR
Cancer Immunol Immunother; 1997 Apr; 44(2):97-102. PubMed ID: 9177471
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.
Bhalla AK; Amento EP; Serog B; Glimcher LH
J Immunol; 1984 Oct; 133(4):1748-54. PubMed ID: 6206136
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells.
Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR
Cancer Immunol Immunother; 1996 May; 42(4):213-20. PubMed ID: 8665568
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro.
Müller K; Odum N; Bendtzen K
Immunol Lett; 1993 Feb; 35(2):177-82. PubMed ID: 8389732
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor invasiveness by 1alpha,25-dihydroxyvitamin D3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization.
Young MR; Lozano Y
Clin Exp Metastasis; 1997 Mar; 15(2):102-10. PubMed ID: 9062386
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets.
Matsui T; Nakao Y; Koizumi T; Nakagawa T; Fujita T
Life Sci; 1985 Jul; 37(1):95-101. PubMed ID: 2989641
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes.
Reichel H; Koeffler HP; Tobler A; Norman AW
Proc Natl Acad Sci U S A; 1987 May; 84(10):3385-9. PubMed ID: 3033646
[TBL] [Abstract][Full Text] [Related]
10. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes.
Provvedini DM; Manolagas SC
J Clin Endocrinol Metab; 1989 Apr; 68(4):774-9. PubMed ID: 2564005
[TBL] [Abstract][Full Text] [Related]
11. Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25(OH)2D3.
Pedrozo HA; Schwartz Z; Rimes S; Sylvia VL; Nemere I; Posner GH; Dean DD; Boyan BD
J Bone Miner Res; 1999 Jun; 14(6):856-67. PubMed ID: 10352093
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
13. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.
Ly LH; Zhao XY; Holloway L; Feldman D
Endocrinology; 1999 May; 140(5):2071-6. PubMed ID: 10218956
[TBL] [Abstract][Full Text] [Related]
14. Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3.
Hodler B; Evêquoz V; Trechsel U; Fleisch H; Stadler B
Immunobiology; 1985 Nov; 170(4):256-69. PubMed ID: 3002965
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
16. Signal-dependent pleiotropic regulation of lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3: potent modulation of the hormonal effects by phorbol esters.
Hustmyer FG; Girasole G; Manolagas SC
Immunology; 1992 Dec; 77(4):520-6. PubMed ID: 1493924
[TBL] [Abstract][Full Text] [Related]
17. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL
Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959
[TBL] [Abstract][Full Text] [Related]
19. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
Penna G; Adorini L
J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo.
Dean DD; Boyan BD; Schwart Z; Muniz OE; Carreno MR; Maeda S; Howell DS
Endocrine; 2001 Apr; 14(3):311-23. PubMed ID: 11444427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
